BSE filing, NSE: ZENOTECH. Summary written from the filing by ALFA Finder's alert engine.
Zenotech Laboratories Ltd: key numbers
- Share price
- ₹37.80
- Market cap
- ₹230.7 Cr
- Revenue (annual)
- ₹43.61 Cr
- Net profit (annual)
- ₹-1.07 Cr
- P/E (TTM)
- -54.2×Sector 46.1×
- Promoter holding
- 68.84%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenotech Laboratories Ltd
All →Zenotech Laboratories Q2 FY27 Results: Net Loss of ₹2.6 Cr, Loss Widens
Zenotech Laboratories Ltd reported revenue from operations of ₹6.1 Cr (-40.2% YoY) and a net loss of ₹2.6 Cr for Q2 FY27.
- Key figure
- Net loss ₹2.6 Cr
Zenotech Laboratories Board Meeting Date
Zenotech Laboratories will hold a board meeting on October 28, 2026, to consider and approve the unaudited financial results for the period ended September 30, 2026.
Zenotech Laboratories Annual General Meeting
Zenotech Laboratories Limited concluded its 37th Annual General Meeting. Shareholders approved the adoption of financial statements and re-appointment of Mr. Jignesh Anantray Goradia as Director.
Zenotech Laboratories Annual General Meeting
Zenotech Laboratories Limited will hold its 37th Annual General Meeting on September 25, 2026, via video conferencing. The cut-off date for voting is September 18, 2026.
Zenotech Laboratories Q1 FY27 Results: Net Loss of ₹0.5 Cr
Zenotech Laboratories Ltd reported revenue from operations of ₹9.6 Cr (+11.6% YoY) and a net loss of ₹0.5 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.5 Cr
Zenotech Laboratories Board Meeting Date
Zenotech Laboratories will hold a board meeting on July 28, 2026. The board will consider unaudited standalone financial results for the June 2026 quarter.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.